Sort by
Refine Your Search
-
Post Summary Research Fellow The Substance Use and Mental Health Interventions using Digital Technology (SUMIT) project team formed and initiated a strategic all-Ireland engagement process over
-
opportunity has arisen to join the Department of Economics at Cork University Business School to conduct a health technology assessment of Electrochemotherapy for skin cancer treatment in Ireland. The primary
-
Responsibilities of the Post Conduct research and development on sign language recognition using computer vision and machine learning techniques. Lead the implementation of inference models suitable for mobile and
-
advancements in trustworthy AI and Software Engineering. Post status: Specific Purpose Contract Hours of Post: 39 hours per week Salary: Appointment will be made on the SFI Team Member Salary Scale for New Post
-
process (e.g. HRB, SFI, IRC, Wellcome Trust) are eligible for Senior Research Fellow title and appointment. For an information package including full details of the post, selection criteria and application
-
functions; establishing processes for long-term sustainability of analyses that work towards near ‘’real time’’ data analytics; and setting the stage for Ireland to take its place in the global discourse
-
and related projects will be encouraged. Application Procedure Applicants should submit a cover letter and full Curriculum Vitae to include the names and contact details of 2 referees (including email
-
activities and the coordination of research aspects, ensuring compliance, innovation, and efficient project execution across academic, industrial, and clinical partners. Application Procedure Applicants should
-
, neurologists, neuroimagers, PPI members, biostatisticians/trial methodologists, and bioengineers. Application Procedure Applicants should submit the following documents via e-mail (in PDF format only): A cover
-
delivered to the lungs to treat infections that may be resistant to oral therapy. The Research Fellow in TCD will be responsible for undertaking biopharmaceutical studies on human lung cells in vitro and